Confusion Reigns In UK CBD Market As Regulatory Vacuum Allowed To Continue

Major retailers LloydsPharmacy and Holland & Barrett remain unfazed by the regulatory chaos surrounding cannabidiol (CBD) in the UK, while pharmacy groups become increasingly concerned that their members may be selling controlled substances due to the possible presence of tetrahydrocannabinol (THC).

CBD Molecule
• Source: Shutterstock

While the UK’s Food Standards Agency considers how to implement the European Food Safety Authority’s decision to classify cannabidiol (CBD) as a novel food, concerns are now being raised by pharmacy groups as to whether CBD oils being sold as food supplements could be considered controlled drugs due to the presence of psychoactive by-product tetrahydrocannabinol (THC).

However, major retailers are standing firmly behind their decision to begin selling CBD products. LloydsPharmacy owner McKesson Corp. and...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Regulation

More from Policy & Regulation